RR DTC: Active Surveillance vs Initiating Systemic Therapy
A brief review of when it is appropriate to initiate systemic therapy in patients with differentiated thyroid cancer as opposed to continuing active surveillance.
Source: onclive.com
Stay updated with breaking news from Select Trial. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A brief review of when it is appropriate to initiate systemic therapy in patients with differentiated thyroid cancer as opposed to continuing active surveillance.